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PRELIMINARY EXPERIENCE WITH THE
GLUTAMIC OXALOACETIC TRANSAMINASE DETERMINATION
IN ACUTE MYOCARDIAL INFARCTION IN HUMANS
EDWARD M C C A L L PRIEST, M.D.,* DONALD G . R E M P , Ph.D.**

DAN H . BASINSKI, Ph.D.** AND LAURIE DICKSON, M.D.***

Transaminase is an enzyme which catalyzes the tranfer of the amino group of a
dicarboxylic amino acid to a keto acid to form a second amino acid and a second
keto acid, thereby accomplishing the procfcss of transamination. This reaction was
first described by Braunstein and Kritzman in 1938. Since that time investigators
have simplified the original and rather complex methods of assaying transaminase
activity, and have established the presence of this activity in various tissues of the
human body''^-'^''''. Glutamic-oxaloacetic transaminase, one of several different such
enzymes, has been established as one of the most widely distributed, being found in
decreasing concentration in the myocardium, liver, skeletal muscle and kidney. The
advent of a reasonably practical method for assay of transaminase activity in human
serum allows a more widespread utilization of this test as a clinical tool.
Use of this determination has recently been instituted here on a limited scale.
This is a review of those reports appearing in current literature and leading to or
supporting our decision to investigate the procedure, and a report of our preliminary
findings. Assays were made on the serum of patients admitted for definite or suspected
myocardial infarction either transmural or non-transmural. Two serial assays, 24 hours
apart, were made. No attempt was made to follow the evolution of the reaction until
increased activity returned to a normal level, except in two cases. Patients suspected
of having co-existing destructive disease of the liver, skeletal muscle and/or kidney,
conditions which may give rise to positive assays, were eliminated.
LaDue, Wroblewski and Karmen^' have reported the only work done in humans
in which a series of patients with myocardial infarction are included. After measuring
transaminase activity in 50 normal individuals these investigators reported a normal
range of 10 to 40 units. Activity in sera of 30 patients having incurred transmural
infarctions yielded values of 100 to 6000 units on at least one occasion during the
first five days following onset of the infarct. The sera of only 2 patients, of a total of
22 patients studied, with arteriosclerotic heart disease uncomplicated by myocardial
infarction exhibited elevated levels of activity. This elevation was minimal. Increased
activity could be obtained from sera of patients with destructive inflammatory lesions
of the liver and kidney or lesions allowing tissue destruction due to sudden circulatory
derangement in these organs. However, these yields were substantially below levels
obtained in sera of patients with myocardial infarction.
To substantiate these findings this same group working alone and in conjunction
with a second group'-' produced experimental infarcts in a total of 21 dogs. In 12
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animals plastic microspheres were introduced into the coronary circulation resulting
in coronary embolization and myocardial infarction. In the remaining 9, ligatures were
placed about the coronary arteries and subsequently these arteries were closed after
sufficient time had elapsed for the dogs to recover from effects of the anesthesia and
thoracotomy. Since liver damage due to anesthesia or tissue destruction due to surgical
procedure caused increased transaminase activity no ligations were done in the latter
group until this activity had returned to normal and so remained for several days. In
each instance of infarction a prompt and sustained elevation of transaminase activity
was found. Following death portions of infarcted and healthy myocardium were removed. After homoginization of these sections transaminase activity was determined
in each homoginate. Much less activity was consistently found in homoginates of infarcted myocardium than in homoginates of healthy myocardium.
The spectrophotometric method of Karmen, Wroblewski, and LaDue' was used for
the assay of transaminase activity. The method has previously proven reliable by
comparison of paired sera assay using the quantitative paper chromatographic technique.
Assay of activity is predicated upon the measurement of the rate of oxydation of
DPN.2H to DPN-)- by oxyaloacetate, obtained during the transamination of aspartate
and alpha-ketoglutarate (see Figure 1). The rate may be followed at wave length
340 mu in the model DU Beckman spectrophotometer. One unit of glutamic-oxaloacetic
transaminase activity represents a decrease in optical density of 0.001/cc of serum/
minute when measured at this wave length under specified conditions.
FIGURE I
Reactions Utilized in the Assay of Glutamic Oxaloacetic Transaminase by the Spectrophotometric
Method.
Transaminase
Aspartate -|- alpha-Ketoglutarate
>Oxaloacetate -|- L-Glutamate
Malic
Dehydrogenase
Oxaloacetate - f DPN.2H

AL-Malate + DPN

One unit of Glutamic Oxaloacetic Transamina.se Activity represents a decrease in optical density
of 0.001/cc of serum/minute when measured at wave length 340 mu at room temperature.

TABLE 1
Maximal Glutamic-Oxaloacetic Transaminase Activity in Nine Patients With Proven Myocardial
Infarction.
Patient Number

Units
1
2
3
4
5
6
7
8
9
Capital letters following units of activity indicate whether this reaction fell below or
preceding reaction.
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of Activity
55 F
55 F
136 R
73 F
94 F
720 R
62
50 R
54 R
above the

Assays on three normal sera here have yielded values of 8 units, 14 units and 38
units. Twelve patients admitted to the cardiology service with proven or suspected
infarcts have had serum transaminase assays on a minimum of two specimens. Nine
patients had at least one serum yielding elevated activity, more than 40 units, (Table 1)
each patient having EKG evidence of acute infarction. Three patients exhibited normal
assays. Two of these did not have infarctions and the third incurred the infarction
10 days previous to admission.
One patient with a transmural posterior infarct had serial determination daily
for 3 days. The first assay yielded 290 units, the second 580 units and the third 720
units. Death occurred during the night of the 3rd day.
One patient with a non-transmural anteroseptal infarction had serial determinations,
done daily on each of 5 days. Units of activity in order were 12, 50, 32, 20 and 28.
It would seem that we may conclude from review of existing reports and our preliminary experience that: (1) the spectrophotometric assay of glutamic-oxaloacetic
transaminase is a reasonably practical and reliable laboratory procedure. (2) increased
activity may be found in sera of patients having incurred either transmural or nontransmural myocardial infarction. (3) increase in activity may be found within a
short time after the occurrence of the infarct and may be sustained for a period of a
few days or may return promptly to normal. (4) that cellular destruction in the liver
or kidney gives rise to increased transaminase activity. (5) further utilization of the
test is warranted.
It would seem reasonable to suspect that the degree of increase of transaminase
activity is related to the amount of tissue damaged, but it probably is premature to
declare that degree of damage may be estimated from the amount of elevation found.
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